Following successful internships with Southampton and Reading Universities over the past two years, Lein is once again taking advantage of this valuable source of knowledgeable support and has engaged Sushmita Poudel to fulfill the role of mathematics intern.
Sushmita, who is a mathematician from the University of Reading, will be working on the processing of new clinical data being collected in Lein’s current clinical trial on volunteers with Type 1 diabetes.
Having outgrown our old offices we are delighted to have moved to the new state of the art building at the Reading Enterprise Centre. The move is a sign of our continued development and growth with the new facilities providing larger offices, enhanced infrastructure, dedicated laboratories and our own testing room for clinical work.
The Reading Enterprise Centre, based on the University of Reading campus, brings together a community of innovation-led and technology-based businesses and places Lein closer to a number of its academic partners.
Lein were delighted to welcome Rob Wilson, MP for Reading East, to their offices in Reading on Friday 21st January. Rob was joined by Ivan Griffin, Madeleine Hallward, and Guy Bilgorri from the National Endowment for Science, Technology and the Arts (NESTA).
NESTA, who alongside Seven Spires Investments and the UMIP Premier Fund, support Lein in its medical device development programme, are the UK's foremost independent experts on how innovation can solve the country's economic and social challenges.
Whilst taking a tour of the Lein laboratories, Rob Wilson commented: “Diabetes is a growing problem around the world. Lein’s research has great potential to both improve the quality of life for people with diabetes and reduce this condition’s ever increasing financial burden on the healthcare system. It is very exciting that this innovative technology is being developed in the heart of Reading, and I look forward to watching the company grow.”
Dr Dan Daly, director and co- founder of Lein, remarked “with Rob Wilson’s experience as an entrepreneur, we know that he understands the challenges facing growing businesses. We have ambitious targets for our technology to stake a claim in the market for blood glucose monitoring, which is estimated to be worth over $10bn.”
Lein successfully completes KTP with Durham University more
Lein featured in Optics.org more
Lein achieves ISO9001 certification more